Delivery Order SPE2DB25D3202-SPE2DB25FTAZB

This is a $6,459.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a medical product. There is no set-aside designation, indicating open competition. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, with a ceiling value of $2,776.43 and a period of performance through December 16, 2024. The contract is not designated as a set-aside. As a prime contractor, AmerisourceBergen Drug Corp is responsible for providing the specified...

This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $8,056.66 and an ultimate completion date of October 28, 2024. The award is a firm fixed-price contract, which is not designated as a set-aside. It is a child contract of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...

This is a $3,143.14 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The order has an ultimate completion date of July 2, 2025. The contract is not set aside and represents a single delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC,...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a specialty medication. The award has a ceiling value of $1,578.00 and an ultimate completion date of October 21, 2024. The contract is a Firm Fixed Price type, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed price pricing type and a ceiling value of $6,049.00. It does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this award, which is a child contract under a larger indefinite delivery contract (IDC) with DLA valued at up...

This federal contract award, with ID SPE2DB22D3004|SPE2DB25FQN13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $2,750.45 and a period of performance through May 2, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not set aside for any...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a total ceiling value of $13,340.60 and a period of performance through June 17, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition....

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the provision of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a diabetes treatment medication. The contract has a firm fixed price pricing type, a ceiling value of $3,023.39, and a period of performance extending through June 27, 2025. It is not designated as a set-aside contract, indicating open competition....

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $3,788.02 and an ultimate completion date of July 3, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp also holds a...